Penetration of vancomycin into mediastinal and cardiac tissues in humans.
作者信息
Martin C, Alaya M, Mallet M N, Viviand X, Ennabli K, Said R, De Micco P
机构信息
Department of Anesthesia and Intensive Care, Hospital Nord, Marseilles, France.
出版信息
Antimicrob Agents Chemother. 1994 Feb;38(2):396-9. doi: 10.1128/AAC.38.2.396.
Abstract
Vancomycin penetration into heart tissues (valves, myocardium, auricles, and pericardium) and mediastinal tissues (fat and sternal bone) was evaluated after two regimens of vancomycin administration. Ten patients were given 15 mg of vancomycin per kg of body weight before anesthesia. Ten other patients received the same dose and then a second 7.5-mg/kg dose at the time of initiation of cardiopulmonary bypass. Similar and satisfactory vancomycin tissue penetrations were observed in both groups. However, for some patients in the two groups, vancomycin levels in tissue were less than the MICs for potential pathogens (Staphylococcus aureus and Staphylococcus epidermidis).
摘要
相似文献
1
Penetration of vancomycin into mediastinal and cardiac tissues in humans.
Antimicrob Agents Chemother. 1994 Feb;38(2):396-9. doi: 10.1128/AAC.38.2.396.
2
Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.
Antimicrob Agents Chemother. 1996 Mar;40(3):812-5. doi: 10.1128/AAC.40.3.812.
3
[Penetration of vancomycin in cardiac and mediastinal tissues in humans].
Pathol Biol (Paris). 1994 May;42(5):520-4.
4
Penetration of vancomycin in uninfected sternal bone.
Antimicrob Agents Chemother. 1992 Nov;36(11):2539-41. doi: 10.1128/AAC.36.11.2539.
5
[Penetration of ceftriaxone (1 or 2 gr intravenous) into mediastinal and cardiac tissues in man].
Pathol Biol (Paris). 1995 Apr;43(4):364-9.
6
Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
Antimicrob Agents Chemother. 1992 Nov;36(11):2493-6. doi: 10.1128/AAC.36.11.2493.
7
Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
Antimicrob Agents Chemother. 1990 Mar;34(3):398-401. doi: 10.1128/AAC.34.3.398.
8
The Effect of Modified Ultrafiltration on Serum Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery.
J Cardiothorac Vasc Anesth. 2019 Jan;33(1):102-106. doi: 10.1053/j.jvca.2018.06.004. Epub 2018 Jun 19.
9
A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX).
J Pharm Biomed Anal. 1998 Nov;18(3):367-72. doi: 10.1016/s0731-7085(98)00095-8.
10
Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery.
Ther Drug Monit. 2000 Dec;22(6):661-7. doi: 10.1097/00007691-200012000-00004.
引用本文的文献
1
Antibiotic-loaded bone cement fixation technique combined with bilateral pectoralis major muscle flaps tension-free management for sternal infection after midline sternotomy.
J Cardiothorac Surg. 2024 May 14;19(1):289. doi: 10.1186/s13019-024-02749-0.
2
Potential Failure of Vancomycin Dosing Using AUC/MIC in a Patient With Purulent Methicillin-Resistant Pericarditis.
J Pharm Technol. 2023 Apr;39(2):95-98. doi: 10.1177/87551225221149732. Epub 2023 Jan 23.
3
Impact of Antibiotic Prophylaxis on Surgical Site Infections in Cardiac Surgery.
Antibiotics (Basel). 2023 Jan 4;12(1):85. doi: 10.3390/antibiotics12010085.
4
The combined application of antibiotic-loaded bone cement and vacuum sealing drainage for sternal reconstruction in the treatment of deep sternal wound infection.
J Cardiothorac Surg. 2022 Aug 26;17(1):209. doi: 10.1186/s13019-022-01951-2.
5
An antibiotic loaded ceramic sternum to treat destroyed infected sternum: 4 cases.
J Thorac Dis. 2020 Mar;12(3):209-216. doi: 10.21037/jtd.2020.01.70.
6
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK Observations.
CPT Pharmacometrics Syst Pharmacol. 2018 Apr;7(4):237-250. doi: 10.1002/psp4.12279. Epub 2018 Feb 15.
7
Systemic antibiotic therapy for chronic osteomyelitis in adults.
Clin Infect Dis. 2012 Feb 1;54(3):393-407. doi: 10.1093/cid/cir842. Epub 2011 Dec 12.
8
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.
Clin Pharmacokinet. 2009;48(2):89-124. doi: 10.2165/00003088-200948020-00002.
9
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
Clin Pharmacokinet. 2008;47(12):793-805. doi: 10.2165/0003088-200847120-00004.
10
Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.
Antimicrob Agents Chemother. 1997 May;41(5):1150-5. doi: 10.1128/AAC.41.5.1150.
本文引用的文献
1
The effective period of preventive antibiotic action in experimental incisions and dermal lesions.
Surgery. 1961 Jul;50:161-8.
2
Bioactive antibiotic levels in the human aorta.
Surgery. 1982 Dec;92(6):1068-71.
3
Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.
Clin Pharmacokinet. 1982 May-Jun;7(3):234-51. doi: 10.2165/00003088-198207030-00004.
4
Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen.
J Thorac Cardiovasc Surg. 1983 Jun;85(6):933-5.
5
Netilmicin prophylaxis in open-heart surgery.
J Antimicrob Chemother. 1984 Jan;13 Suppl A:59-65. doi: 10.1093/jac/13.suppl_a.59.
6
Basic principles in the use of prophylactic antibiotics.
J Antimicrob Chemother. 1984 Sep;14 Suppl B:33-7. doi: 10.1093/jac/14.suppl_b.33.
7
Sequestration of fentanyl by the cardiopulmonary bypass (CPBP).
Eur J Clin Pharmacol. 1984;27(1):51-6. doi: 10.1007/BF00553154.
8
Loss of nitroglycerin to cardiopulmonary bypass apparatus.
Crit Care Med. 1983 Jan;11(1):50-2. doi: 10.1097/00003246-198301000-00013.
9
Antimicrobial prophylaxis in surgery.
N Engl J Med. 1986 Oct 30;315(18):1129-38. doi: 10.1056/NEJM198610303151805.
10
Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition.
Antimicrob Agents Chemother. 1988 May;32(5):631-5. doi: 10.1128/AAC.32.5.631.
Zotero 插件